基本信息
views: 8
Career Trajectory
Bio
No content for now
Research Interests
Papers共 157 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
E. S. Trofimova,M. V. Zykova,M. G. Danilets,A. A. Ligacheva,E. Yu. Sherstoboev, N. S. Selivanova, L. A. Azarkina, A. M. Zhirkova, Yu. Zhang,I. V. Perminova,V. V. Zhdanov,M. V. Belousov
Разработка и регистрация лекарственных средствno. 2 (2024): 164-170
Maria V. Zykova,Kristina A. Bratishko,Evgeny E. Buyko, Lyudmila A. Azarkina,Vladimir V. Ivanov,Dmitrii A. Mihalyov, Evgeniya S. Trofimova,Marina G. Danilets,Anastasia A. Ligacheva,Andrey I. Konstantinov, Alexander A. Ufandeev,Evgenia S. Rabtsevich, Larisa A. Drygunova,Anastasia P. Zima, Sergey R. Bashirov,Elena V. Udut,Mikhail V. Belousov
MOLECULESno. 7 (2024)
MOLECULAR PHARMACEUTICSno. 4 (2024): 1919-1932
Maria V. Zykova,Maria R. Karpova,Yu Zhang, Marianna V. Chubik, Daria M. Shunkova, Lyudmila A. Azarkina,Dmitrii A. Mihalyov,Andrey I. Konstantinov,Evgenii V. Plotnikov,Alexey N. Pestryakov, Irina V. Perminova,Mikhail V. Belousov
NANOMATERIALSno. 17 (2024)
M. V. Filonova,S. V. Krivoshchekov, N. S. Zinner, D. A. Isakov, Ya. E. Reshetov,A. A. Churin,M. V. Belousov
Russian Journal of Plant Physiologyno. 4 (2024): 1-9
JOURNAL OF CONTROLLED RELEASE (2024): 468-478
Разработка и регистрация лекарственных средствno. 2 (2024): 84-92
A. A. Ligacheva,M. G. Danilets,E. I. Gulina, N. S. Selivanova,E. S. Trofimova,E. Yu. Sherstoboev,E. Yu. Avdeeva, Ya. E. Reshetov,S. V. Krivoshchekov,V. V. Zhdanov,M. V. Belousov
NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY (2023)
Load More
Author Statistics
#Papers: 157
#Citation: 582
H-Index: 12
G-Index: 20
Sociability: 6
Diversity: 2
Activity: 22
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn